Synthomer (LON:SYNT – Free Report) had its price objective hoisted by Deutsche Bank Aktiengesellschaft from GBX 92 to GBX 100 in a report published on Wednesday morning,Digital Look reports. They currently have a hold rating on the stock.
SYNT has been the subject of a number of other research reports. Peel Hunt restated a “buy” rating and issued a GBX 200 target price on shares of Synthomer in a research note on Tuesday. Berenberg Bank increased their price objective on Synthomer from GBX 60 to GBX 100 and gave the company a “hold” rating in a report on Wednesday, May 6th. Finally, Jefferies Financial Group restated a “hold” rating and issued a GBX 65 price objective on shares of Synthomer in a research note on Thursday, April 30th. One analyst has rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Synthomer currently has an average rating of “Hold” and a consensus price target of GBX 119.
Check Out Our Latest Analysis on Synthomer
Synthomer Stock Performance
Synthomer (LON:SYNT – Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported GBX (4.30) EPS for the quarter. Synthomer had a negative return on equity of 13.27% and a negative net margin of 6.81%. On average, sell-side analysts anticipate that Synthomer will post 12.962963 EPS for the current fiscal year.
About Synthomer
Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide.
Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,800 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.
Further Reading
- Five stocks we like better than Synthomer
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.
